Literature DB >> 7584105

The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer.

A Kass-Eisler1, E Falck-Pedersen, D H Elfenbein, M Alvira, P M Buttrick, L A Leinwand.   

Abstract

Important aspects of successful adenovirus gene transfer include the amount and persistence of gene expression, the ability to readminister virus and the localization of virus-directed gene expression to target organs. Our objective in this study was to use a single recombinant adenovirus bearing a quantifiable reporter gene [chloramphenicol acetyltransferase (CAT)] to establish the parameters which define the limits of adenovirus gene expression in a rat model. First, we determined how the route of virus administration affected the amount, duration and distribution of expression in different tissues and in rats of different developmental stages. All routes resulted in infection of all tissues tested. Surprisingly, the most efficient and widespread gene transfer was achieved by intracardiac muscle injection. The high levels of CAT protein that can be produced in a liver (< or = 1.7 mg) or a heart (< or = 196 micrograms) 5 days after infection suggest that the amount of gene product will not be a limitation in the use of adenovirus. Following peak activity at 5 days after infection, a gradual decline of CAT expression was observed in all tissues assayed; by 80 days neither CAT activity nor adenovirus DNA were detectable. In addition, adults could not be boosted by a second administration of virus, presumably due to the presence of high levels of neutralizing antibodies. The limited persistence of gene expression could be circumvented when virus was injected into neonates. Blocking T lymphocyte expansion by cyclosporine enhanced the persistence of CAT gene product over a 25-day period in heart and lung but not in liver compared with control animals.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7584105

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  44 in total

Review 1.  Prospects for gene therapy in cystic fibrosis.

Authors:  A Jaffé; A Bush; D M Geddes; E W Alton
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

2.  Lake Tahoe invitation meeting 2002.

Authors: 
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

3.  A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector.

Authors:  Shuji Kubo; Kohnosuke Mitani
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.

Authors:  K B Elkon; C C Liu; J G Gall; J Trevejo; M W Marino; K A Abrahamsen; X Song; J L Zhou; L J Old; R G Crystal; E Falck-Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 5.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

6.  Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo.

Authors:  R Agah; P A Frenkel; B A French; L H Michael; P A Overbeek; M D Schneider
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

7.  Identification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifs.

Authors:  Denis Y Logunov; Olga V Zubkova; Anna S Karyagina-Zhulina; Eugenia A Shuvalova; Andrei P Karpov; Maxim M Shmarov; Irina L Tutykhina; Yulia S Alyapkina; Natalia M Grezina; Natalia A Zinovieva; Lev K Ernst; Alexsandr L Gintsburg; Boris S Naroditsky
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

8.  GammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk.

Authors:  Maureen N Ajuebor; Yijun Jin; Griffin L Gremillion; Robert M Strieter; Qingling Chen; Patrick A Adegboyega
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  A simple technique to establish a long-term adenovirus mediated gene transfer to the heart of newborn mice.

Authors:  Marina Jerebtsova; Xuehai Ye; Patricio E Ray
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2009-06

10.  Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.

Authors:  J Gall; A Kass-Eisler; L Leinwand; E Falck-Pedersen
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.